Rational drug-design approach supported with thermodynamic studies — a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational drug-design approach supported with thermodynamic studies — a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-29
DOI
10.1038/s41598-019-47404-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2
- (2017) Maria Winiewska et al. PLoS One
- Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2
- (2015) Maria Winiewska et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity
- (2015) G. Cozza et al. BIOCHEMICAL JOURNAL
- Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α
- (2015) Maria Winiewska et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Acetoxymethyl Ester of Tetrabromobenzimidazole–Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells
- (2015) Kaido Viht et al. BIOCONJUGATE CHEMISTRY
- Selective Bisubstrate Inhibitors with Sub-nanomolar Affinity for Protein Kinase Pim-1
- (2013) Ramesh Ekambaram et al. ChemMedChem
- A subnanomolar fluorescent probe for protein kinase CK2 interaction studies
- (2012) Erki Enkvist et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Isomeric Mono-, Di-, and Tri-Bromobenzo-1H-Triazoles as Inhibitors of Human Protein Kinase CK2α
- (2012) Romualda Wąsik et al. PLoS One
- Saturation Transfer Difference NMR Studies of the Interaction of the Proteinkinase CK2 with Peptides
- (2012) Christoph Rauber et al. PROTEIN AND PEPTIDE LETTERS
- Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases
- (2010) Kurt J Cox et al. Future Medicinal Chemistry
- Diversity of Bisubstrate Binding Modes of Adenosine Analogue–Oligoarginine Conjugates in Protein Kinase A and Implications for Protein Substrate Interactions
- (2010) Alexander Pflug et al. JOURNAL OF MOLECULAR BIOLOGY
- Relative Role of Halogen Bonds and Hydrophobic Interactions in Inhibition of Human Protein Kinase CK2α by Tetrabromobenzotriazole and Some C(5)-Substituted Analogues
- (2010) Romualda Wąsik et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Bisubstrate Inhibitors of Protein Kinases: from Principle to Practical Applications
- (2009) Darja Lavogina et al. ChemMedChem
- Peptide Inhibitors Targeting Protein Kinases
- (2009) Hagit Eldar-Finkelman et al. CURRENT PHARMACEUTICAL DESIGN
- Kinase conformations: A computational study of the effect of ligand binding
- (2009) Volkhard Helms et al. PROTEIN SCIENCE
- High-field solution NMR spectroscopy as a tool for assessing protein interactions with small molecule ligands
- (2008) Andria L. Skinner et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole
- (2002) Roberto Battistutta et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started